vs

Side-by-side financial comparison of Precipio, Inc. (PRPO) and TECOGEN INC. (TGEN). Click either name above to swap in a different company.

Precipio, Inc. is the larger business by last-quarter revenue ($6.8M vs $5.3M, roughly 1.3× TECOGEN INC.). Precipio, Inc. runs the higher net margin — 7.7% vs -75.1%, a 82.8% gap on every dollar of revenue. On growth, Precipio, Inc. posted the faster year-over-year revenue change (28.4% vs -12.5%). Precipio, Inc. produced more free cash flow last quarter ($291.0K vs $-2.6M). Over the past eight quarters, Precipio, Inc.'s revenue compounded faster (40.0% CAGR vs -7.3%).

Precipio, Inc. is a specialty diagnostic firm that develops and provides advanced oncology, genetic, and rare disease testing solutions. It primarily serves healthcare providers, clinical laboratories, and patients across the United States, with a core focus on enhancing diagnostic accuracy and improving patient health outcomes.

PRPO vs TGEN — Head-to-Head

Bigger by revenue
PRPO
PRPO
1.3× larger
PRPO
$6.8M
$5.3M
TGEN
Growing faster (revenue YoY)
PRPO
PRPO
+40.9% gap
PRPO
28.4%
-12.5%
TGEN
Higher net margin
PRPO
PRPO
82.8% more per $
PRPO
7.7%
-75.1%
TGEN
More free cash flow
PRPO
PRPO
$2.9M more FCF
PRPO
$291.0K
$-2.6M
TGEN
Faster 2-yr revenue CAGR
PRPO
PRPO
Annualised
PRPO
40.0%
-7.3%
TGEN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PRPO
PRPO
TGEN
TGEN
Revenue
$6.8M
$5.3M
Net Profit
$526.0K
$-4.0M
Gross Margin
45.9%
36.8%
Operating Margin
7.9%
-77.8%
Net Margin
7.7%
-75.1%
Revenue YoY
28.4%
-12.5%
Net Profit YoY
244.1%
-236.7%
EPS (diluted)
$0.36
$-0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRPO
PRPO
TGEN
TGEN
Q4 25
$6.8M
$5.3M
Q3 25
$6.9M
$7.2M
Q2 25
$5.6M
$7.3M
Q1 25
$4.9M
$7.3M
Q4 24
$5.3M
$6.1M
Q3 24
$5.3M
$5.6M
Q2 24
$4.5M
$4.7M
Q1 24
$3.5M
$6.2M
Net Profit
PRPO
PRPO
TGEN
TGEN
Q4 25
$526.0K
$-4.0M
Q3 25
$-79.0K
$-2.1M
Q2 25
$74.0K
$-1.5M
Q1 25
$-884.0K
$-659.9K
Q4 24
$-365.0K
$-1.2M
Q3 24
$-626.0K
$-930.4K
Q2 24
$-1.2M
$-1.5M
Q1 24
$-2.1M
$-1.1M
Gross Margin
PRPO
PRPO
TGEN
TGEN
Q4 25
45.9%
36.8%
Q3 25
43.6%
30.4%
Q2 25
43.2%
33.8%
Q1 25
43.6%
44.3%
Q4 24
49.8%
45.0%
Q3 24
43.1%
44.1%
Q2 24
38.1%
44.0%
Q1 24
26.5%
41.6%
Operating Margin
PRPO
PRPO
TGEN
TGEN
Q4 25
7.9%
-77.8%
Q3 25
-0.9%
-29.2%
Q2 25
-14.6%
-19.4%
Q1 25
-17.5%
-8.2%
Q4 24
-6.3%
-18.7%
Q3 24
-11.3%
-15.5%
Q2 24
-26.8%
-31.2%
Q1 24
-59.6%
-17.0%
Net Margin
PRPO
PRPO
TGEN
TGEN
Q4 25
7.7%
-75.1%
Q3 25
-1.1%
-29.7%
Q2 25
1.3%
-20.1%
Q1 25
-18.0%
-9.1%
Q4 24
-6.9%
-19.5%
Q3 24
-11.9%
-16.5%
Q2 24
-27.1%
-32.5%
Q1 24
-59.8%
-17.9%
EPS (diluted)
PRPO
PRPO
TGEN
TGEN
Q4 25
$0.36
$-0.14
Q3 25
$-0.05
$-0.07
Q2 25
$0.05
$-0.06
Q1 25
$-0.59
$-0.03
Q4 24
$-0.22
$-0.05
Q3 24
$-0.42
$-0.04
Q2 24
$-0.83
$-0.06
Q1 24
$-1.46
$-0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRPO
PRPO
TGEN
TGEN
Cash + ST InvestmentsLiquidity on hand
$2.7M
$12.4M
Total DebtLower is stronger
$83.0K
Stockholders' EquityBook value
$14.6M
$21.6M
Total Assets
$21.3M
$37.0M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRPO
PRPO
TGEN
TGEN
Q4 25
$2.7M
$12.4M
Q3 25
$2.3M
$15.3M
Q2 25
$1.1M
$1.6M
Q1 25
$1.0M
$4.1M
Q4 24
$1.4M
$5.4M
Q3 24
$1.1M
$1.3M
Q2 24
$1.3M
$841.9K
Q1 24
$776.0K
$1.5M
Total Debt
PRPO
PRPO
TGEN
TGEN
Q4 25
$83.0K
Q3 25
Q2 25
Q1 25
Q4 24
$383.0K
Q3 24
Q2 24
Q1 24
Stockholders' Equity
PRPO
PRPO
TGEN
TGEN
Q4 25
$14.6M
$21.6M
Q3 25
$13.7M
$25.5M
Q2 25
$12.3M
$9.1M
Q1 25
$11.7M
$9.6M
Q4 24
$12.1M
$10.2M
Q3 24
$11.9M
$11.3M
Q2 24
$12.1M
$12.2M
Q1 24
$12.8M
$13.7M
Total Assets
PRPO
PRPO
TGEN
TGEN
Q4 25
$21.3M
$37.0M
Q3 25
$21.2M
$41.5M
Q2 25
$18.8M
$28.4M
Q1 25
$17.8M
$29.7M
Q4 24
$17.0M
$31.1M
Q3 24
$17.0M
$27.5M
Q2 24
$17.3M
$27.2M
Q1 24
$16.6M
$28.5M
Debt / Equity
PRPO
PRPO
TGEN
TGEN
Q4 25
0.01×
Q3 25
Q2 25
Q1 25
Q4 24
0.03×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRPO
PRPO
TGEN
TGEN
Operating Cash FlowLast quarter
$366.0K
$-2.6M
Free Cash FlowOCF − Capex
$291.0K
$-2.6M
FCF MarginFCF / Revenue
4.3%
-49.3%
Capex IntensityCapex / Revenue
1.1%
0.9%
Cash ConversionOCF / Net Profit
0.70×
TTM Free Cash FlowTrailing 4 quarters
$359.0K
$-10.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRPO
PRPO
TGEN
TGEN
Q4 25
$366.0K
$-2.6M
Q3 25
$10.0K
$-3.6M
Q2 25
$353.0K
$-2.6M
Q1 25
$-44.0K
$-1.2M
Q4 24
$565.0K
$4.2M
Q3 24
$41.0K
$-207.3K
Q2 24
$500.0K
$-157.9K
Q1 24
$-667.0K
$248.2K
Free Cash Flow
PRPO
PRPO
TGEN
TGEN
Q4 25
$291.0K
$-2.6M
Q3 25
$-44.0K
$-3.6M
Q2 25
$294.0K
$-2.7M
Q1 25
$-182.0K
$-1.3M
Q4 24
$4.0M
Q3 24
$-68.0K
$-489.6K
Q2 24
$-609.6K
Q1 24
$143.3K
FCF Margin
PRPO
PRPO
TGEN
TGEN
Q4 25
4.3%
-49.3%
Q3 25
-0.6%
-50.6%
Q2 25
5.2%
-37.7%
Q1 25
-3.7%
-17.9%
Q4 24
66.6%
Q3 24
-1.3%
-8.7%
Q2 24
-12.9%
Q1 24
2.3%
Capex Intensity
PRPO
PRPO
TGEN
TGEN
Q4 25
1.1%
0.9%
Q3 25
0.8%
1.0%
Q2 25
1.0%
2.0%
Q1 25
2.8%
1.8%
Q4 24
2.1%
Q3 24
2.1%
5.0%
Q2 24
9.6%
Q1 24
1.7%
Cash Conversion
PRPO
PRPO
TGEN
TGEN
Q4 25
0.70×
Q3 25
Q2 25
4.77×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRPO
PRPO

Segment breakdown not available.

TGEN
TGEN

Installation Services$4.5M84%
Products Segment$460.5K9%
Other$394.7K7%

Related Comparisons